期刊文献+

高危型HPV检测与液基细胞学在宫颈癌前病变筛查中的效果比较 被引量:11

Comparision of the Performance of High Risk HPV Testing With Liquid-based Cytology in Cervical Cancer Screening
下载PDF
导出
摘要 目的比较高危型HPV检测与液基细胞学(TCT)在宫颈癌前病变筛查中的临床效果。方法回顾性分析我中心妇科门诊有宫颈疾病并行组织病理学检查的患者827例,其中每例患者均曾行HPV检测或TCT检测,比较高危型HPV检测和液基细胞学(TCT)检测在筛查CIN2及以上病变中的阳性率、灵敏度、特异度。结果高危型HPV检测在筛查CIN2及以上病变中的阳性率(75.6%)高于TCT检测(38.6%),两组间比较差异有统计学意义(P<0.001);方法学比较高危型HPV检测灵敏度(95.9%)高于TCT检测(47.9%),特异度(80%)也高于TCT检测(61.2%)。结论高危型HPV检测作为筛选癌前病变的方法优于TCT检测,具有重要的临床价值。 Objective To assess the performance of HPV testing compared with liquid-based cytology for cervical cancer screening.Methods 827 women who were attending routine cervical screening were enrolled.Cervial specimens were.Obtained for liquid-based cytology or HPV DNA testing.Colposcopy and diagnostic biopsies were done on everyone.Comparision of the two methods of positive rate,sensitivity,specificity.Results HPV testing positive rate(75.6%) is significantly higher than TCT testing(38.6%);methodlogical HPV testing is higher than that of TCT testing in sensitivity(95.9% vs 47.9%) and in specificity(80% vs 61.2%).Conclusion HPV testing has important clinical application because it can improve detection sensitivity and specificity on early screening of cervical cancer.
出处 《中国实验诊断学》 2012年第9期1654-1656,共3页 Chinese Journal of Laboratory Diagnosis
关键词 宫颈癌 人乳头瘤病毒 液基细胞学 cervical cancer human papilloma virus liquid based cytology
  • 相关文献

参考文献7

  • 1熊小英,邱永秀,林霞.HPV DNA/液基细胞学检测诊断宫颈病变的临床意义[J].中国妇产科临床杂志,2006,7(2):97-99. 被引量:15
  • 2Lee SA,Kang D,Seo SS,ET AL. Multiple HPV infection in cervi- cal cancer screened by HPV DNA chip [J]. Cancer Lett,2003,198 (2):187.
  • 3Anttila A, Kotaniemi-Talone L, Leinonen M, et al. Rate of cervicaleancer,sevrer intraepithelial neoplasia, and adenocarcinorrm in situ in prinary HPV DNA screening with cytology triage: randomised study within organised screening programme[J]. BMJ, 2010,340 : c1804.
  • 4Ronco G,Giorgi-Rossi P, Carozzi F, et al, and the New Technoli- gies for Cervical Cancer screening(NTCC) Working Group. Effi- cacy of human papillomarivus testing for the detection of invasion cervical cancers and cervical intraepithelial neoplasia: a random- ised controlled trial[J]. Lancet Oneol, 2010,11 : 249.
  • 5Naucler P, Ryd W, Tornberg S, et al, Human papillomarivus and Papanicolaou tests to screen for cervical cancer[J]. N Engl J Med, 2007,357 : 1589.
  • 6Mayrand MH,Duarte-Franco E, Rodrigues I, et al, Human papil- lomarivus Orivus DNA versus Papanicolaou screening tests for cervical cancer[J].N Engl J Med 2007,357 : 1579.
  • 7Philip E Castle, Mask H Stoler, Thomas C Wright Jr, et al. Per- formance of carcinogenic human papillomavirus testing ang HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study[J].Lancet Oncol, 2011,12 : 880.

二级参考文献6

  • 1[1]Schiffman MH,Bauer MH,Hoover RN,et al.Epidemiologic evidence showing that human papillomavirus infection cause most cervical intraepithelial neoplasm.J Natl cancer Inst,1993,85:958-964.
  • 2[3]Denise Zielinski G,Snijders PJ,Rozendaal L,et al.High-rish HPV testing in women with borderline and mild dyskaryosis:ling-term follow-up data and clinical relevance.J Pathol,2001,195:300-306.
  • 3[4]Ho GYH,Bierman R,Beardsley L,et al.Nature history of cervicovaginal papillomavirus infection as measured by repeated DNA testing in adolescent and young women.N Engl J Med,1998,338:423-428.
  • 4[5]Wallin KL,Wiklung F,Angstrom T,et al.Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.N Engl J Med,1999,341:1633-1638.
  • 5[6]Petry KU,Menton M,Menton S,et al.Inclusion of HPV testing in routine cervical cancer screenig for womwn above 29years in Germany:results for 8 466 patients.Br J Cancer,2003,88:1570-1577.
  • 6郎景和.迎接子宫颈癌预防的全球挑战与机遇[J].中华妇产科杂志,2002,37(3):129-131. 被引量:884

共引文献14

同被引文献116

  • 1米贤军,白宝敏,熊小英,万波,彭学呜,钟守军,黄兆华.宫颈癌及癌前病变筛查方法对比研究[J].医药论坛杂志,2005,26(24):16-18. 被引量:10
  • 2王静,马金龙,王家耀,王强修.MCM蛋白与肿瘤[J].医学与哲学(B),2007,28(3):41-42. 被引量:4
  • 3袁新荣,李红薇.TCT、HR-HPV检测及宫颈活检在宫颈早期病变中的诊断价值[J].中国医药导报,2007,4(05Z):13-15. 被引量:33
  • 4回允中主译.女性生殖道病理学[M].北京:北京大学医学出版社,2005.795-797.
  • 5乔友林.中国妇女人乳头瘤病毒感染和子宫颈癌的流行病学研究现状及其疫苗预防前景[J].中华流行病学杂志,2007,28(10):937-940. 被引量:92
  • 6Sangrajrang S,Chokvanitphong V,Sumetchotimaytha W,et al.Evaluationof health status of a population underwent routine medical check up at thehigh risk screening clinic in National Cancer lnstitute[J].Asian Pac J CancerPrev,2012;13(11):5759-5762.
  • 7Chevarie-Davis M,Ramanakumar AV5Ferenczy A,et al.Assessment of theperformance of algorithms for cervical cancer screening:Evidence from theLudwig-McGiIl cohort study[J].Gynecol Oncol,2013; 128(3):415-419.
  • 8Walboomers JM, Jacobs MV, Manos MM, et al. Human papilloma vi- rus is a necessary cause of invasive cervical cancer worldwide [ J ]. Patho|, 1999,189 ( 1 ) :12 - 19.
  • 9Mocarska A,Starosiawska E, Zelazowska-Cieslihska I, et al. Epide- miology and risk factors of the cervical squamous cell carcinoma [J]. Pol MerkurLekarski,2012,33(194):101 -106.
  • 10Solomon D, Davey D, Kurman R,et al. The 2001 Bethesda System: terminology for reporting results of eervical cytology [ J ]. JAMA, 2002,287(16) :2114 -2119.

引证文献11

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部